Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	123.65	146.65	131.54	123.65	141.52	203.52
Short-Term Investments	-	-	138.37	199.46	202.75	296.33
Cash & Short-Term Investments	123.65	146.65	269.91	323.11	344.27	499.85
Cash Growth	-44.04%	-45.67%	-16.46%	-6.15%	-31.12%	24.31%
Accounts Receivable	2.59	15.18	16.27	10.19	5.15	0.27
Other Current Assets	1.83	2.07	3.14	7.53	7.34	7.2
Total Current Assets	128.07	163.9	289.32	340.83	356.75	507.31
Net Property, Plant & Equipment	18.3	19.66	47.05	45.71	59.22	43.29
Long-Term Investments	-	-	-	104.02	93.1	120.07
Other Long-Term Assets	2.98	2.98	5.22	8.59	5.25	6.81
Total Assets	149.34	186.53	341.59	499.15	514.32	677.48
Accounts Payable	4.33	2.61	5.49	8.27	9.51	5.05
Accrued Expenses	21.25	32.61	45.86	34.56	31.3	20.19
Current Portion of Long-Term Debt	7.5	5	5	-	-	-
Current Portion of Leases	6.7	6.03	14.65	12.16	11.08	10.31
Unearned Revenue	-	-	6.22	8.22	8.22	11.33
Total Current Liabilities	39.78	46.25	77.23	63.22	60.11	46.88
Long-Term Debt	47.18	53.61	52.43	-	-	-
Long-Term Leases	10.6	12.07	20.38	24.37	32.86	16.07
Other Long-Term Liabilities	47.38	47.32	57.28	62.47	60.67	60.89
Total Long-Term Liabilities	105.15	113	130.09	86.84	93.53	76.96
Total Liabilities	144.93	159.25	207.32	150.06	153.64	123.84
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,658	1,656	1,602	1,580	1,442	1,412
Accumulated Other Comprehensive Income	-	-	0.27	0.2	-3.6	-0.49
Retained Earnings	-1,653	-1,629	-1,468	-1,231	-1,078	-857.7
Shareholders' Equity	4.41	27.29	134.27	349.1	360.68	553.64
Total Liabilities & Equity	149.34	186.53	341.59	499.15	514.32	677.48
Total Debt	71.97	76.71	92.47	36.54	43.95	26.38
Net Cash (Debt)	51.67	69.94	177.45	286.58	300.33	473.47
Net Cash Growth	-26.11%	-60.59%	-38.08%	-4.58%	-36.57%	25.93%
Net Cash Per Share	0.56	0.79	2.15	3.77	4.37	7.00
Book Value	4.41	27.29	134.27	349.1	360.68	553.64
Book Value Per Share	0.05	0.31	1.63	4.60	5.25	8.19
Tangible Book Value	4.41	27.29	134.27	349.1	360.68	553.64
Tangible Book Value Per Share	0.05	0.31	1.63	4.60	5.25	8.19

SEC Filings: 10-K · 10-Q